Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) PT at $5.38

Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has received an average rating of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 […]

Related Keywords

Chicago ,Illinois ,United States ,Paulb Manning , ,Cantor Fitzgerald ,Canaccord Genuity Group ,Taysha Gene Therapies Inc ,Taysha Gene Therapies Company Profile ,Chicago Partners Investment Group ,Nasdaq ,Quantum Private Wealth ,Citigroup Inc ,Dynamic Advisor Solutions ,Needham Company ,Capital Investment Advisors ,Taysha Gene Therapies ,Get Free Report ,Marketbeat Ratings ,Advisor Solutions ,Investment Advisors ,Partners Investment Group ,Private Wealth ,Gene Therapies ,Get Free ,Taysha Gene Therapies Daily ,Nasdaq Tsha ,Ntsha ,Medical ,Ratings ,Consensus ,